Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Erratum to "A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction" [J Hepatol 67 (2017) 669-679].

Suárez-Amarán L, Usai C, Di Scala M, Godoy C, Ni Y, Hommel M, Palomo L, Segura V, Olagüe C, Vales A, Ruiz-Ripa A, Buti M, Salido E, Prieto J, Urban S, Rodríguez-Frias F, Aldabe R, González-Aseguinolaza G.

J Hepatol. 2018 Jul;69(1):262-264. doi: 10.1016/j.jhep.2018.04.003. No abstract available.

PMID:
29776712
2.

N-terminal acetylation modulates Bax targeting to mitochondria.

Alves S, Neiri L, Chaves SR, Vieira S, Trindade D, Manon S, Dominguez V, Pintado B, Jonckheere V, Van Damme P, Silva RD, Aldabe R, Côrte-Real M.

Int J Biochem Cell Biol. 2018 Feb;95:35-42. doi: 10.1016/j.biocel.2017.12.004. Epub 2017 Dec 9.

PMID:
29233735
3.

A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.

Suárez-Amarán L, Usai C, Di Scala M, Godoy C, Ni Y, Hommel M, Palomo L, Segura V, Olagüe C, Vales A, Ruiz-Ripa A, Buti M, Salido E, Prieto J, Urban S, Rodríguez-Frias F, Aldabe R, González-Aseguinolaza G.

J Hepatol. 2017 Oct;67(4):669-679. doi: 10.1016/j.jhep.2017.05.010. Epub 2017 May 18. Erratum in: J Hepatol. 2018 May 15;:.

PMID:
28527664
4.

NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma.

Neri L, Lasa M, Elosegui-Artola A, D'Avola D, Carte B, Gazquez C, Alve S, Roca-Cusachs P, Iñarrairaegui M, Herrero J, Prieto J, Sangro B, Aldabe R.

Oncotarget. 2017 Jun 20;8(25):40967-40981. doi: 10.18632/oncotarget.17332.

5.
6.

Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis.

Gil-Farina I, Di Scala M, Salido E, López-Franco E, Rodríguez-García E, Blasi M, Merino J, Aldabe R, Prieto J, Gonzalez-Aseguinolaza G.

J Immunol. 2016 Sep 15;197(6):2145-56. doi: 10.4049/jimmunol.1600228. Epub 2016 Aug 10.

7.

Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.

Aldabe R, Suárez-Amarán L, Usai C, González-Aseguinolaza G.

Pathogens. 2015 Feb 12;4(1):46-65. doi: 10.3390/pathogens4010046. Review.

8.

Cold Preservation of Human Adult Hepatocytes for Liver Cell Therapy.

Duret C, Moreno D, Balasiddaiah A, Roux S, Briolotti P, Raulet E, Herrero A, Ramet H, Biron-Andreani C, Gerbal-Chaloin S, Ramos J, Navarro F, Hardwigsen J, Maurel P, Aldabe R, Daujat-Chavanieu M.

Cell Transplant. 2015;24(12):2541-55. doi: 10.3727/096368915X687020. Epub 2015 Jan 23.

PMID:
25622096
9.

Image analysis for the quantitative comparison of stress fibers and focal adhesions.

Elosegui-Artola A, Jorge-Peñas A, Moreno-Arotzena O, Oregi A, Lasa M, García-Aznar JM, De Juan-Pardo EM, Aldabe R.

PLoS One. 2014 Sep 30;9(9):e107393. doi: 10.1371/journal.pone.0107393. eCollection 2014.

10.

Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.

Larrea E, Echeverria I, Riezu-Boj JI, Aldabe R, Guembe L, Sola I, Civeira MP, Sarobe P, Prieto J.

J Hepatol. 2014 Mar;60(3):482-9. doi: 10.1016/j.jhep.2013.10.016. Epub 2013 Oct 26.

PMID:
24418171
11.

Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes.

Moreno D, Balasiddaiah A, Lamas O, Duret C, Neri L, Guembe L, Galarraga M, Larrea E, Daujat-Chavanieu M, Muntane J, Maurel P, Riezu JI, Prieto J, Aldabe R.

PLoS One. 2013 Sep 24;8(9):e74948. doi: 10.1371/journal.pone.0074948. eCollection 2013.

12.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.

Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, Gastaminza P, Civeira MP, Sarobe P, Prieto J.

Gut. 2014 Apr;63(4):665-73. doi: 10.1136/gutjnl-2012-304377. Epub 2013 Jun 20.

PMID:
23787026
13.

Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny.

Balasiddaiah A, Moreno D, Guembe L, Prieto J, Aldabe R.

J Physiol Biochem. 2013 Dec;69(4):835-45. doi: 10.1007/s13105-013-0260-9. Epub 2013 May 30.

PMID:
23715756
14.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Van Damme P, Lasa M, Polevoda B, Gazquez C, Elosegui-Artola A, Kim DS, De Juan-Pardo E, Demeyer K, Hole K, Larrea E, Timmerman E, Prieto J, Arnesen T, Sherman F, Gevaert K, Aldabe R.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54. doi: 10.1073/pnas.1210303109. Epub 2012 Jul 18.

15.

Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle.

Molina-Jimenez F, Benedicto I, Dao Thi VL, Gondar V, Lavillette D, Marin JJ, Briz O, Moreno-Otero R, Aldabe R, Baumert TF, Cosset FL, Lopez-Cabrera M, Majano PL.

Virology. 2012 Mar 30;425(1):31-9. doi: 10.1016/j.virol.2011.12.021. Epub 2012 Jan 24.

16.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, Echeverria I, Sarobe P, Herrero I, Sangro B, Prieto J, Lasarte JJ.

J Hepatol. 2011 Mar;54(3):422-31. doi: 10.1016/j.jhep.2010.07.014. Epub 2010 Sep 26.

17.

Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex.

Ametzazurra A, Gázquez C, Lasa M, Larrea E, Prieto J, Aldabe R.

BMC Proc. 2009 Aug 4;3 Suppl 6:S4. doi: 10.1186/1753-6561-3-S6-S4.

18.

The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.

Benedicto I, Molina-Jiménez F, Bartosch B, Cosset FL, Lavillette D, Prieto J, Moreno-Otero R, Valenzuela-Fernández A, Aldabe R, López-Cabrera M, Majano PL.

J Virol. 2009 Aug;83(16):8012-20. doi: 10.1128/JVI.00038-09. Epub 2009 Jun 10.

19.

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.

Bortolanza S, Bunuales M, Alzuguren P, Lamas O, Aldabe R, Prieto J, Hernandez-Alcoceba R.

Cancer Gene Ther. 2009 Sep;16(9):703-12. doi: 10.1038/cgt.2009.12. Epub 2009 Feb 20.

20.

Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells.

Larrea E, Aldabe R, Gonzalez I, Segura V, Sarobe P, Echeverria I, Prieto J.

J Virol. 2009 Apr;83(7):3298-311. doi: 10.1128/JVI.02167-08. Epub 2009 Jan 21.

21.

Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor.

Liu J, HuangFu WC, Kumar KG, Qian J, Casey JP, Hamanaka RB, Grigoriadou C, Aldabe R, Diehl JA, Fuchs SY.

Cell Host Microbe. 2009 Jan 22;5(1):72-83. doi: 10.1016/j.chom.2008.11.008.

22.

Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.

Benedicto I, Molina-Jiménez F, Barreiro O, Maldonado-Rodríguez A, Prieto J, Moreno-Otero R, Aldabe R, López-Cabrera M, Majano PL.

Hepatology. 2008 Oct;48(4):1044-53. doi: 10.1002/hep.22465.

PMID:
18802961
23.

Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis.

Ametzazurra A, Larrea E, Civeira MP, Prieto J, Aldabe R.

Oncogene. 2008 Dec 11;27(58):7296-306. doi: 10.1038/onc.2008.332. Epub 2008 Sep 15.

PMID:
18794801
24.

HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.

Luquin E, Larrea E, Civeira MP, Prieto J, Aldabe R.

Antiviral Res. 2007 Nov;76(2):194-7. Epub 2007 Aug 6.

PMID:
17675168
25.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, Civeira MP, Heeney JL, Rollier C, Verstrepen B, Wakita T, Borrás-Cuesta F, Lasarte JJ, Prieto J.

J Virol. 2007 Apr;81(7):3662-6. Epub 2007 Jan 17.

26.

Gene therapy for viral hepatitis.

Gonzalez-Aseguinolaza G, Crettaz J, Ochoa L, Otano I, Aldabe R, Paneda A.

Expert Opin Biol Ther. 2006 Dec;6(12):1263-78. Review.

PMID:
17223736
27.

Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation.

Guitart A, Riezu-Boj JI, Elizalde E, Larrea E, Berasain C, Aldabe R, Civeira MP, Prieto J.

J Gen Virol. 2005 Nov;86(Pt 11):3065-74.

28.

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.

Larrea E, Aldabe R, Molano E, Fernandez-Rodriguez CM, Ametzazurra A, Civeira MP, Prieto J.

Gut. 2006 Aug;55(8):1188-96. Epub 2005 Aug 24.

29.

IFN-alpha5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2',5'-oligoadenylate synthetase than IFN-alpha2 in liver cells.

Larrea E, Aldabe R, Riezu-Boj JI, Guitart A, Civeira MP, Prieto J, Baixeras E.

J Interferon Cytokine Res. 2004 Aug;24(8):497-503.

PMID:
15320963
30.

Embryonic expression of Krüppel-like factor 6 in neural and non-neural tissues.

Laub F, Aldabe R, Ramirez F, Friedman S.

Mech Dev. 2001 Aug;106(1-2):167-70.

31.

Developmental expression of mouse Krüppel-like transcription factor KLF7 suggests a potential role in neurogenesis.

Laub F, Aldabe R, Friedrich V Jr, Ohnishi S, Yoshida T, Ramirez F.

Dev Biol. 2001 May 15;233(2):305-18.

32.

Overexpression of a novel zinc-finger protein induces apoptosis in NIH3T3 fibroblasts.

Laub F, Aldabe R, Ou J, Ramirez F.

Genomics. 2000 Dec 15;70(3):375-80.

PMID:
11161788
33.

Cloning the cDNA for a new human zinc finger protein defines a group of closely related Krüppel-like transcription factors.

Matsumoto N, Laub F, Aldabe R, Zhang W, Ramirez F, Yoshida T, Terada M.

J Biol Chem. 1998 Oct 23;273(43):28229-37.

34.

Poliovirus protein 2BC increases cytosolic free calcium concentrations.

Aldabe R, Irurzun A, Carrasco L.

J Virol. 1997 Aug;71(8):6214-7.

35.

Membrane permeabilization by poliovirus proteins 2B and 2BC.

Aldabe R, Barco A, Carrasco L.

J Biol Chem. 1996 Sep 20;271(38):23134-7.

36.

Effects of poliovirus 2A(pro) on vaccinia virus gene expression.

Feduchi E, Aldabe R, Novoa I, Carrasco L.

Eur J Biochem. 1995 Dec 15;234(3):849-54.

37.

Expression of poliovirus 2Apro in mammalian cells: effects on translation.

Aldabe R, Feduchi E, Novoa I, Carrasco L.

FEBS Lett. 1995 Dec 11;377(1):1-5.

38.

Efficient cleavage of p220 by poliovirus 2Apro expression in mammalian cells: effects on vaccinia virus.

Aldabe R, Feduchi E, Novoa I, Carrasco L.

Biochem Biophys Res Commun. 1995 Oct 24;215(3):928-36.

PMID:
7488063
39.

Induction of membrane proliferation by poliovirus proteins 2C and 2BC.

Aldabe R, Carrasco L.

Biochem Biophys Res Commun. 1995 Jan 5;206(1):64-76.

PMID:
7818552

Supplemental Content

Loading ...
Support Center